Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer
April 19, 2024
April 19, 2024
TAMPA, Florida, April 19 (TNSres) -- Moffitt Cancer Center issued the following news release:
Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center (https://www.moffitt.org/) study published in the journal Immunity offers insight into how lung cancer cells evade the protective immune system, potentially opening a door for novel antibody-based i . . .
Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center (https://www.moffitt.org/) study published in the journal Immunity offers insight into how lung cancer cells evade the protective immune system, potentially opening a door for novel antibody-based i . . .